Skip to main content
ISTH 2023 Main banner
Back

    Peter J. Lenting, PhD

    Principal Investigator, Director of research
    Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixte de Recherche S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France
    Paris, Ile-de-France, France

    Biosketch P.J. Lenting

    Peter Lenting obtained his PhD with honours at the medical faculty of the University of Amsterdam, the Netherlands in 1996. He was appointed associate-professor of haematology at the University Medical Center in Utrecht, the Netherlands in 2000. Between 2007 and 2009, he held a position of Director of Protein Discovery at Crucell Holland (Leiden, the Netherlands). In March 2009, he joined Inserm as Director of Research. His research activities are mainly focussed on the biology of the Factor VIII/von Willebrand factor (FVIII/VWF) complex and their related disorders haemophilia A and von Willebrand disease. He was an elected member of the council of the International Society of Thrombosis and Haemostasis (ISTH; 2012-2018), and chaired of the ISTH-WHO-liaison committee (2012-2018). Dr. Lenting was awarded the Prix Danièle Hermann (Foundation for Cardio-vascular Research, Institut de France; 2009) and more recently the van Creveld medal (Dutch Society of Thrombosis and Haemostasis; 2022) and the Arosenius award (World Hemophilia Foundation; 2022).

    Presentation(s):